Re: Aims Test - When to do?

[Rnlncoh]

In a message dated 3/22/04 11:00:07 PM Eastern Standard Time, [EMAIL PROTECTED] writes: I have no documentation, but it is my understanding that the APA recommends that the AIMs be done every six months for patients on anti-psychotics.  I don't believe there is anything in the Regs nor in the state operations manual that says that AIMs should be done whenever there is a change of dosage, or a change in meds.  Since the AIMs purpose is to identify T.D., why would you do one if you notice it?  Most likely to quantify the movements and monitor improvement if drug is D/C'd, or to prove extent of disability if it doesn't resolve, so doing it when you stop the meds is most likely a good idea from a defense point of view.  Still, I don't believe there is a requirement to do one, and I would have used my favorite, "I'm a dumb blonde" question:   "Well, I want to be certain I can correct this to the letter.  Could you show me in the regulations where it says which way we are to perform AIMs testing."    Corey ----- Original Message ----- I haven't seen any documentation that states the AIMS test has to be done either, except from corporate policy.  We do one on every single OBRA MDS that we do.  So that is at least the admit, 3 quarterlies, and the annual.  And it is done for all psychotropics, whether TD is a side effect or not.  In addition, we also have to do a chemical consent form that lists the name of the drug, what it is being used for, and the side effects, and any alternatives tried instead.  This form is signed by the resident/responsible party and the MDS nurse. It gets changed whenever a med &/or dosage changes.  In addition to that, there is the Chemical Restraint form that we fill out (with same info from the consent form) and the doc has to sign it at least q90 days (which is difficult to get signed).  I like your question though.  Have to go and get some hair dye!    Sherri